Riskpilot← Back to searchSign inGet full accessPHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS
APSActiveCVR 33242840H.C. Andersens Boulevard 48, 1.Research and experimental development on natural sciences and engineering · NACE 7210Est. 201050 employees
Revenue 2024
DKK 72,3M
+13% vs 2023
EBITDA margin
6.3%
+12% vs 2023
Equity ratio
44.8%
Financial strength
Net profit 2024
DKK 3,6M
+14% vs 2023
| Revenue | DKK 72,3M | +13% |
| EBITDA | DKK 4,5M | +12% |
| Net profit | DKK 3,6M | +14% |
| Total assets | DKK 46,6M | +19% |
| Equity | DKK 20,9M | +20% |
| Employees | 50 | — |
Legal name
PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS
CVR number
33242840
Legal form
Anpartsselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
7. oktober 2010
Share capital
DKK 80.000
Employees
50 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af bestyrelsesmedlemmerne i forening eller af et medlem af bestyrelsen eller en direktør hver for sig.
Company purpose
Selskabets formål er at udføre generel klinisk forskning og hermed forbundet virksomhed efter bestyrelsens skøn.
Address
H.C. Andersens Boulevard 48, 1.
Email
fkh@kellerlaw.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 34.746 | 44.686 | 57.090 | 64.002 | 72.284 |
| Staff expenses | -32.101 | -40.700 | -53.511 | -59.945 | -67.759 |
| EBITDA | 2.645 | 3.986 | 3.578 | 4.057 | 4.525 |
| Depreciation & amort. | -22 | -47 | -55 | -49 | -15 |
| EBIT | 2.622 | 3.939 | 3.524 | 4.008 | 4.510 |
| Net financials | 15 | -93 | -30 | -6 | 53 |
| Profit before tax | 2.637 | 3.846 | 3.493 | 4.002 | 4.563 |
| Tax | 580 | 846 | 770 | 888 | 1.009 |
| Net profit | 2.057 | 3.000 | 2.723 | 3.114 | 3.554 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 13.971 | 17.630 | 18.398 | 39.034 | 46.592 |
| Equity | 8.501 | 11.501 | 14.224 | 17.338 | 20.892 |
| Long-term debt | 2.793 | 2.825 | 0 | 0 | 0 |
| Short-term debt | 2.677 | 3.304 | 4.174 | 21.696 | 25.700 |
| Total debt | 5.470 | 6.129 | 4.174 | 21.696 | 25.700 |
EBITDA margin
6.3%
This company
15.8%
Market median
-60% vs market
20202024
Equity ratio
44.8%
This company
38.2%
Market median
+17% vs market
20202024
Return on equity
17.0%
This company
18.4%
Market median
+8% vs market
20202024
Net profit margin
4.9%
This company
8.1%
Market median
-40% vs market
20202024
Asset turnover
1.55×
This company
1.12×
Market median
+38% vs market
20202024
Debt / equity
1.23×
This company
0.62×
Market median
-98% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Founder | 2010 | |
| Former (1) | ||
CS Management | Management | 2010 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2023 | |
| Board of Directors | 2021 | |
| Board of Directors | 2021 | |
| Former (4) | ||
| Chairman | 2011 – 2018 | |
| Board of Directors | 2010 – 2021 | |
| Chairman | 2010 – 2011 | |
| Chairman | 2018 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100% | 100% | 2010 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Colin Shannon | Management | 0 companies |
| Pharm Research Associates (UK) Limited | Founder | 0 companies |
| Timothy Jon McClain | Chairman | 0 companies |
| Christopher John Gray | Board of Directors | 0 companies |
| Thomas Noel O´Leary | Chairman | 0 companies |
| Simon Peter Hollywood | Board of Directors | 0 companies |
| Susan Caroline Stansfield | Chairman | 0 companies |
| John Sheahan | Board of Directors | 0 companies |
| Robert James Leftwich | Chairman | 0 companies |